Gefonib 250 mg Tablet
$66,86
$35,59
Gefonib 250 mg Tablet is an effective treatment option for adult patients diagnosed with advanced non-small cell lung cancer (NSCLC) characterized by mutations in the EGFR gene, particularly in cases where the cancer has metastasized to other areas of the body. This targeted therapy works by inhibiting the activity of the EGFR protein, which plays a crucial role in cancer cell growth and division, ultimately helping to slow disease progression and improve outcomes. It is important to note that Gefonib 250 mg is not recommended for children or adolescents, as its safety and efficacy in these populations have not been established. Patients should be aware of potential side effects, which may include skin rashes, diarrhea, and liver function alterations, and should monitor their health closely during treatment. Regular consultations with a healthcare professional are essential to manage any adverse reactions effectively. As with any medication, adherence to prescribed dosages and ongoing medical supervision are vital for maximizing the benefits of Gefonib in the fight against lung cancer. By choosing this innovative therapy, patients can access a targeted approach that aligns with the latest advancements in oncology.
數量
Active Pharmaceutical Ingredient
Uses
• Gefonib 250 mg tablet is primarily indicated for the treatment of non-small cell lung cancer (NSCLC). This type of lung cancer is characterized by the uncontrolled growth of cells in the lungs. Patients diagnosed with NSCLC may benefit from Gefonib as it targets specific mutations associated with this cancer. By inhibiting certain pathways, Gefonib helps to slow down tumor growth and improve patient outcomes.
• In cases where patients have advanced non-small cell lung cancer, Gefonib 250 mg tablet can be a critical component of their treatment regimen. It is often utilized in patients who have previously undergone chemotherapy and are looking for additional therapeutic options. The efficacy of Gefonib in targeting specific genetic alterations makes it a valuable choice for oncologists. This targeted approach can lead to better management of the disease.
• Gefonib 250 mg tablet is also prescribed for patients with specific genetic markers, such as mutations in the epidermal growth factor receptor (EGFR). These mutations are commonly found in certain subtypes of non-small cell lung cancer. By using Gefonib, healthcare providers can offer a more personalized treatment strategy. This targeted therapy may result in improved response rates and quality of life for patients.
• Additionally, Gefonib 250 mg tablet can be used in combination with other treatments to enhance therapeutic effects in non-small cell lung cancer. Oncologists may recommend Gefonib alongside immunotherapy or radiation, depending on the patient's condition. This multifaceted approach aims to maximize treatment efficacy and address the cancer more comprehensively. The integration of Gefonib can be crucial for achieving better clinical outcomes.
Benefits
Gefonib Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Gefonib 250 Tablet may help to slow the progression of cancer.
Gefonib 250 mg may help reduce the severity of cancer-related symptoms, such as pain and fatigue, which can improve a patient's overall quality of life.
Gefonib Tablet may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
As with all medicines, Gefonib 250 mg Tablet may cause some side effects. If you experience any of these side effects, you should contact your doctor or health care professional as soon as possible. Your doctor may be able to suggest ways in which these side effects can be managed or the severity of them reduced.
Most Common Side Effects
• Tremor
• Hypertension
• Headache
• Increased Potassium levels in the blood
• Hypertension
• Gastrointestinal problems
• Abnormal Growth of Hair
Common Side Effects
• Liver Damage
• Seizures
• Infection
• Kidney Damage
• Memory Problems
• Vision Problems
• Sleeplessness
How To Use
It is recommended to consume Gefonib 250 mg Tablet with or without food. Be sure to swallow the tablet whole with a complete glass of water. Avoid crushing, chewing, or opening the tablet. In case you forget to take a dose, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose and adhere to your regular dosing schedule. Remember not to take two doses simultaneously to compensate for a missed dose.
Safety Advice
• Alcohol: The use of alcohol is generally not recommended while taking Gefonib 250 mg Tablet as it may increase the risk of liver damage. It is advisable to either abstain from alcohol or limit your alcohol intake while taking any medication.
• Kidney: Gefonib 250 mg Tablet is considered safe for patients with mild to moderate kidney disease and no dose adjustment of Gefonib 250 mg is required. However, people with severe kidney disease are advised not to take Gefonib 250 Tablet Tablet. To ensure the safety and effectiveness of your treatment, it is important to have an open discussion with your doctor about all your medical conditions and medications.
• Breastfeeding: It is not advisable to breast-feed while taking Gefonib 250 Tablet as this may cause harm to the baby. Gefonib 250 mg Tablet can pass into breast milk and cause adverse effects. If you are currently breastfeeding and using Gefonib Tablet, it is important to discuss with your doctor the potential risks and benefits of continuing to breastfeed. Your doctor will help you make the decision that is best for you and your baby.
• Liver: Gefonib 250 mg Tablet is considered safe for patients with mild to moderate liver disease, and there is no need to adjust the dose of Gefonib Tablet. However, people with severe liver disease should not use Gefonib 250 mg Tablet. It is important to have an open discussion with your doctor about your medical conditions and medications to ensure that the treatment plan is appropriate for you.
• Pregnancy: Gefonib 250 mg Tablet may be unsafe during pregnancy as animal studies suggest that it may harm the developing fetus. However, if you are pregnant or planning to get pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Gefonib 250 mg Tablet while pregnant. Your doctor will be able to help you make the decision that is best for you and for the health of your baby.
• Driving: Gefonib 250 mg Tablet may cause dizziness, drowsiness, and problems with concentration and coordination, which may impair your ability to drive a vehicle safely. It is important that you follow your doctor's instructions and take the necessary measures, such as avoiding driving or operating heavy machinery, if you experience any of these side effects caused by Gefonib Tablet.